We're here for you with Medication Abortion

About the Case

Access to a Safe, Effective Abortion Medication In Jeopardy

Anti-abortion activists sued the U.S. Food and Drug Administration (FDA) in federal court over the FDA’s approval of mifepristone, one of two medications most commonly used in a medication abortion. Mifepristone is safe, effective, and has been used by more than 5 million people in the United States since the FDA approved it more than 20 years ago.

Over the past several months, the case moved through legal proceedings and mifepristone remained available. In December 2023, the U.S. Supreme Court announced it would consider the case in its current term. If the Court had not agreed to hear the case, rulings from the Fifth Circuit decision would have stood, which significantly limit access to medication abortion. 

Until the Supreme Court rules, mifepristone will remain on the market and accessible in states where abortion is legal. 

This is yet another effort by people opposed to safe, legal abortion to interfere with the health care provider and patient relationship, and make it more difficult for patients to get the medical care they need and deserve. Everyone should have the ability to make decisions about their bodies, health, and futures, without political interference. Equal access to medication abortion helps give everyone the ability to make their own decisions about their lives and futures.

As always, Planned Parenthood of Northern New England will follow evidence-based standards to provide safe, high-quality abortion care and information to patients who come to us for care.